| Date Filed | Type | Description |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2023 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 326 shares
@ $12.89, valued at
$4.2k
Sold 332 shares
@ $12.64, valued at
$4.2k
Sold 346 shares
@ $12.15, valued at
$4.2k
|
|
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 313 shares
@ $13.43, valued at
$4.2k
Sold 5,000 shares
@ $13.44, valued at
$67.2k
Exercised 4,462 restricted stock units
@ $0 |
|
| 03/10/2023 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 40,097 options to buy
@ $15, valued at
$601.5k
Granted 27,160 restricted stock units
@ $0 |
|
| 01/20/2023 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $14.56, valued at
$72.8k
|
|
| 12/16/2022 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $14.64, valued at
$73.2k
|
|
| 11/18/2022 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $16.54, valued at
$82.7k
|
|
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2022 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $16.03, valued at
$80.2k
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 60,846 options to buy
@ $19.59, valued at
$1.2M
Granted 17,850 restricted stock units
@ $0 |
|
| 01/08/2021 |
4
| Greenstein Leonard M. (CFO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 40,999 options to buy
@ $47.25, valued at
$1.9M
|
|
| 10/15/2020 |
3
| Greenstein Leonard M. (CFO) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
| 10/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/28/2013 |
4
| Greenstein Leonard M. (VP Finance & Corp Controller) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Sold 1,253 shares
@ $14.01, valued at
$17.6k
|
|
| 10/02/2012 |
4/A
| Greenstein Leonard M. (VP Finance & Corp Controller) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 14,472 shares
@ $12.62, valued at
$182.6k
|
|
| 09/11/2012 |
4/A
| Greenstein Leonard M. (VP Finance & Corp Controller) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 14,472 shares
@ $12.62, valued at
$182.6k
|
|
| 09/11/2012 |
4
| Greenstein Leonard M. (VP Finance & Corp Controller) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 14,472 shares
@ $13.82, valued at
$200k
|
|